Research Article: Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD- Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization
Introduction:
Hepatocellular carcinoma (HCC) is a malignant tumor associated with high morbidity and mortality. , Although the recommended first-line treatments such as surgical resection for patients with early-stage HCC have the potential to cure, most cases are not candidates. In addition, % of patients have tumor progression and less than % of patients can benefit from curative therapies. Transarterial chemoembolization (TACE) and microwave ablation (MWA) are the commonly local treatment for unresectable HCC. Previous…
Read more